Literature DB >> 8239175

Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation.

D E O'Donnell1, K A Webb.   

Abstract

There is considerable intersubject variability in the perceived intensity of breathlessness for a given level of activity among patients with chronic airflow limitation (CAL). To examine possible factors contributing to this variability we compared breathing pattern parameters, dynamic operational lung volumes, and Borg dyspnea ratings in 23 patients with severe CAL and in 10 healthy age-matched normal subjects during cycle ergometry to symptom-limitation. Patients with CAL had significantly (p < 0.01) higher levels of ventilation (% maximal voluntary ventilation) for a given work rate (slope of VE(%MVV)/WR(% pred max) = 1.51 +/- 0.18 versus 0.63 +/- 0.10; mean +/- SEM) and greater dynamic lung hyperinflation (DH) (change [delta] in end-expiratory lung volume [EELVdyn] = +0.31 +/- 0.11 L versus -0.16 +/- 0.22 L). Compared with normal subjects at a standardized VE (30 L/min), the CAL group was more breathless Borg = 4 +/- 1 versus 2 +/- 1, p < 0.01) and hyperinflated (EELVdyn = 75 +/- 3 versus 46 +/- 6% TLC, p < 0.001; end-inspiratory lung volume [EILVdyn] = 85 +/- 3 versus 67 +/- 5% TLC, p < 0.01). Within the CAL group, change in Borg ratings correlated with delta VE(%MVV) (r = 0.77, p < 0.001) and with slope of VE(%MVV)/WR(% pred max) (r = 0.48, p < 0.01). Regression analysis selected delta EILVdyn (or delta inspiratory reserve volume [delta IRVdyn]) from various dynamic ventilatory parameters as the strongest predictor of delta Borg (r = 0.63, p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8239175     DOI: 10.1164/ajrccm/148.5.1351

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  68 in total

1.  Dyspnea and its interaction with pain.

Authors:  Takashi Nishino
Journal:  J Anesth       Date:  2010-12-14       Impact factor: 2.078

Review 2.  [Acute dyspnoea].

Authors:  U Wagner; C Vogelmeier
Journal:  Internist (Berl)       Date:  2005-09       Impact factor: 0.743

3.  Patterns of dynamic hyperinflation during exercise and recovery in patients with severe chronic obstructive pulmonary disease.

Authors:  I Vogiatzis; O Georgiadou; S Golemati; A Aliverti; E Kosmas; E Kastanakis; N Geladas; A Koutsoukou; S Nanas; S Zakynthinos; C Roussos
Journal:  Thorax       Date:  2005-06-17       Impact factor: 9.139

4.  Physiologic basis for improved pulmonary function after lung volume reduction.

Authors:  Henry E Fessler; Steven M Scharf; Edward P Ingenito; Robert J McKenna; Amir Sharafkhaneh
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

5.  Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD.

Authors:  F Maltais; P LeBlanc; F Whittom; C Simard; K Marquis; M Bélanger; M J Breton; J Jobin
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 6.  Lung volume reduction surgery in chronic obstructive pulmonary disease.

Authors:  L Davies; P M Calverley
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

7.  Regional chest wall volume changes during various breathing maneuvers in normal men.

Authors:  Masafumi Nozoe; Kyoshi Mase; Akimitsu Tsutou
Journal:  J Jpn Phys Ther Assoc       Date:  2011

8.  [Main parameters of lung function in chronic obstructive pulmonary disease (COPD)].

Authors:  J M Marín Trigo
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

Review 9.  Is there any treatment other than drugs to alleviate dyspnea in COPD patients?

Authors:  Nicolino Ambrosino; Guido Vagheggini
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 10.  Hyperinflation and its management in COPD.

Authors:  Luis Puente-Maestu; William W Stringer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.